GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Intermune, Inc. (ITMN) [hlAlert]

Rating:
Buy ITMN
up 270.05 %

Intermune, Inc. (ITMN) rated Buy

Posted on: Wednesday,  Sep 19, 2007  9:25 AM ET by Lazard Capital

Lazard Capital rated Buy Intermune, Inc. (NASDAQ: ITMN) on 09/19/2007, when the stock price was $19.97. Since
then, Intermune, Inc. has gained 270.06% as of 09/26/2014's recent price of $73.90.
If you would have followed this Lazard Capital's recommendation on ITMN, you would have gained 270.05% of your investment in 2564 days.

InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Our goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Our industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/19/2007 9:25 AM Buy
None
19.97
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  401.62 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy